The genetic background of HSZP virus, an HSV1 strain with extensive passage history, was analyzed by parallel comparative sequencing of four relevant genes (UL27/gB, UL41/vhs, UL44/gC and UL53/gK) of HSZP and additional three selected viruses [strains ANGpath, strains KOS(a) and KOS(b) and the prototype strain 17]. Mutation at position 858 (His for Arg) in gB of HSZP was found to be responsible for giant cell formation (syn3gB mutation) similarly as the 855 mutation (Val for Ala) in the gB of ANGpath. No syn1gK mutations were detected in the UL53 gene either of HSZP or of ANGpath viruses. The reduced virulence of HSZP for adult mice after peripheral inoculation, similarly as that of KOS virus, seems to be related (at least in part) to numerous mutations in the gB ectodomain. Of these, two mutations located in the antigenic domain IV were the same in gBHSZP as well as in gBKOS (at amino acids 59 and 79), at least two (amino acids 313 and 553) were specific for gBKOS, while one mutation (Ser for Ala at position 108) was specific for gBHSZP. The abolished shutoff function of the HSZP virus was related to at least four out of six specific mutations seen in the vhs polypeptide (vhsHSZP) encoded by the UL41 gene, of which three (amino acids 374, 386, 392) were clustered in the semiconservative box A of vhsHSZP (the truncation of which abrogates the inhibition provided by this protein) and one mutation (at amino acid 18) was situated in the highly conservative locus I of vhsHSZP. In addition, the two vhsKOS specific mutations (amino acids 19 and 317) not found in vhsHSZP, enhanced the early host shutoff function of the vhsKOS protein. Finally, gCHSZP had two specific mutations (amino acids 137 and 147) located in the antigenic domain II of gC, which is responsible for binding of HSV1 virions to the glycosoaminoglycan (GAG) receptor. When expressed in Sf21 cells using the recombinant baculovirus system (Bac-to-Bac), gCHSZP and gCKOS showed no essential antigenic differences.

Institute of Virology Slovak Academy of Sciences Bratislava Slovak Republic

See more in PubMed

J Virol. 1984 Nov;52(2):566-74 PubMed

J Gen Virol. 1994 Apr;75 ( Pt 4):743-52 PubMed

J Virol. 1985 Jan;53(1):128-36 PubMed

Acta Virol. 2000 Apr;44(2):99-108 PubMed

J Clin Microbiol. 1984 Feb;19(2):235-9 PubMed

J Virol. 1985 Jan;53(1):243-53 PubMed

Acta Virol. 1995 Feb;39(1):37-49 PubMed

Biochem Cell Biol. 1994 Jan-Feb;72(1-2):20-5 PubMed

Annu Rev Biochem. 1978;47:251-76 PubMed

J Gen Virol. 1988 Jul;69 ( Pt 7):1531-74 PubMed

J Gen Virol. 1994 Aug;75 ( Pt 8):2053-8 PubMed

Acta Virol. 1994 Apr;38(2):77-88 PubMed

Virology. 1993 Apr;193(2):1028-32 PubMed

Virus Genes. 1994 Jan;8(1):83-6 PubMed

Acta Virol. 1990 Aug;34(4):305-20 PubMed

J Virol. 1995 Aug;69(8):4863-71 PubMed

Virus Genes. 1997;15(2):155-9 PubMed

Virus Res. 1999 Mar;60(1):81-6 PubMed

J Virol. 1993 Aug;67(8):4566-79 PubMed

J Mol Biol. 1978 Mar 25;120(1):97-120 PubMed

J Virol. 1988 Aug;62(8):2596-604 PubMed

Virology. 1989 Sep;172(1):11-24 PubMed

Virology. 1997 Jan 6;227(1):153-9 PubMed

J Virol. 1993 Apr;67(4):2191-201 PubMed

J Virol. 1994 Dec;68(12):8277-81 PubMed

J Virol. 1983 Apr;46(1):83-93 PubMed

Virology. 1995 Aug 20;211(2):491-506 PubMed

J Gen Virol. 1987 Sep;68 ( Pt 9):2389-95 PubMed

J Gen Virol. 1990 Apr;71 ( Pt 4):889-95 PubMed

J Gen Virol. 1990 Jun;71 ( Pt 6):1387-90 PubMed

Virus Genes. 2000;20(1):27-33 PubMed

Acta Virol. 1984 Nov;28(6):457-63 PubMed

Virus Res. 1996 Jul;43(1):33-44 PubMed

J Virol. 1990 Feb;64(2):856-63 PubMed

Arch Virol. 1992;123(1-2):209-14 PubMed

J Virol. 1993 Oct;67(10):5948-54 PubMed

Arch Virol. 1993;129(1-4):167-82 PubMed

Glycobiology. 1999 Jan;9(1):73-81 PubMed

J Virol. 1991 Mar;65(3):1090-8 PubMed

J Gen Virol. 1987 Jul;68 ( Pt 7):1909-19 PubMed

Virus Res. 1992 Nov;26(2):99-112 PubMed

Virology. 1987 Dec;161(2):395-402 PubMed

Acta Virol. 1998 Feb;42(1):41-5 PubMed

Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection